Who Paid My Doc
PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Device Tissue Diagnostics
PDI 04015630972197
General payments
$9,501
Research payments
$652,784
Through program year 2025, $9,501 in general payments and $652,784 in research payments were reported against PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody (Tissue Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $185 | 9 |
| 2024 | General | $1,226 | 4 |
| 2024 | Research | $15,523 | 2 |
| 2023 | General | $1,671 | 51 |
| 2023 | Research | $563,792 | 13 |
| 2022 | General | $6,347 | 4 |
| 2022 | Research | $73,468 | 2 |
| 2021 | General | $72 | 4 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
72 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.